<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-pharmaceutics-12-00171">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Jong</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Thanh</surname>
    <given-names>T.T.</given-names>
   </name>
   <name>
    <surname>Khanh</surname>
    <given-names>T.H.</given-names>
   </name>
   <name>
    <surname>Hien</surname>
    <given-names>V.M.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>G.J.D.</given-names>
   </name>
   <name>
    <surname>Chau</surname>
    <given-names>N.V.</given-names>
   </name>
   <name>
    <surname>Cam</surname>
    <given-names>B.V.</given-names>
   </name>
   <name>
    <surname>Qui</surname>
    <given-names>P.T.</given-names>
   </name>
   <name>
    <surname>Ha</surname>
    <given-names>D.Q.</given-names>
   </name>
   <name>
    <surname>Guan</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2005</year>
  <volume>353</volume>
  <fpage>2667</fpage>
  <lpage>2672</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa054512</pub-id>
  <?supplied-pmid 16371632?>
  <pub-id pub-id-type="pmid">16371632</pub-id>
 </element-citation>
</ref>
